Platelet separation from whole blood in an aqueous two-phase system with water-soluble polymers

Journal of Pharmacological Sciences

Volumn 101, Issue 1, 2006, Pages 91-97

  Sumida, Emi ^a   Iwasaki, Yasuhiko ^a   Akiyoshi, Kazunari ^a   Kasugai, Shohei ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Aqueous two phase system; P selectin; Platelet rich plasma; Polymer; Separation

Indexed keywords

PADGEM PROTEIN; PHOSPHORYLCHOLINE; POLYASPARTIC ACID; POLYGLUTAMIC ACID; POLYMER;

ANTICOAGULATION; AQUEOUS HUMOR FLOW; AQUEOUS SOLUTION; ARTICLE; CELL MEMBRANE; CENTRIFUGATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTOPHERESIS;

EID: 33646779572     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0060062     Document Type: Article

References (38)

1. Harrison P, Cramer EM. Platelet alpha-granules. Blood Rev. 1993;7:52-62.
2. Assoian RK, Grotendorst GR, Miller DM, Sporn MB. Cellular transformation by coordinated action of three peptide growth factors from human platelets. Nature. 1984;309:804-806.
3. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004;91:4-15.
4. Slater M, Patava J, Kingham K, Mason RS. Involvement of platelets in stimulating osteogenic activity. J Orthop Res. 1995;13:655-663.
5. Hsieh SC, Graves DT. Pulse application of platelet-derived growth factor enhances formation of a mineralizing matrix while continuous application is inhibitory. J Cell Biochem. 1998;69:169-180.
6. Whitman DH, Berry RL. A technique for improving the handling of particulate cancellous bone and marrow grafts using platelet gel. J Oral Maxillofac Surg. 1998;56:1217-1218.
7. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:638-646.
8. Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants. 1999;14:529-535.
9. de Obarrio JJ, Arauz-Dutari JI, Chamberlain TM, Croston A. The use of autologous growth factors in periodontal surgical therapy: platelet gel biotechnology - case reports. Int J Periodontics Restorative Dent. 2000;20:486-497.
10. Kassolis JD, Rosen PS, Reynolds MA. Alveolar ridge and sinus augmentation utilizing platelet-rich plasma in combination with freeze-dried bone allograft: case series. J Periodontol. 2000;71:1654-1661.
11. Lowery GL, Kulkarni S, Pennisi AE. Use of autologous growth factors in lumbar spinal fusion. Bone. 1999;25:47S-50S.
12. Buckley RC, Breazeale EE, Edmond JA, Brzezienski MA. A simple preparation of autologous fibrin glue for skin-graft fixation. Plast Reconstr Surg. 1999;103:202-206.
13. Man D, Plosker H, Winland-Brown JE. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg. 2001;107:229-237; discussion 238-239.
14. Weibrich G, Kleis WK. Curasan PRP kit vs. PCCS PRP system. Collection efficiency and platelet counts of two different methods for the preparation of platelet-rich plasma. Clin Oral Implants Res. 2002;13:437-443.
15. Weibrich G, Kleis WK, Buch R, Hitzler WE, Hafner G. The Harvest Smart PRePTM system versus the Friadent-Schutze platelet-rich plasma kit. Clin Oral Implants Res. 2003;14:233-239.
16. Tozum TF, Demiralp B. Platelet-rich plasma: a promising innovation in dentistry. J Can Dent Assoc. 2003;69:664.
17. Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg. 1997;55:1294-1299.
18. Michelson AD. Flow cytometry: a clinical test of platelet function. Blood. 1996;87:4925-4936.
19. Landi EP, Roveri EG, Ozelo MC, Annichino-Bizzacchi JM, Origa AF, de Carvalho Reis AR, et al. Effects of high platelet concentration in collecting and freezing dry platelets concentrates. Transfus Apher Sci. 2004;30:205-212.
20. Walter H, Brooks DE, Sharp KA, Albertsson P-A. Partitioning in aqueous two-phase systems: theory, methods, uses, and applications to biotechnology. In: Walter H, Brooks DE, Fisher D, editors. Academic Press Inc. 1985.
21. Hatti-Kaul R. Aqueous two-phase systems: methods and protocols. In: Hatti-Kaul R, editor. Methods in biotechnology. Totowa, New Jersey: Humana Press; 2000.
22. Rito-Palomares M. Practical application of aqueous two-phase partition to process development for the recovery of biological products. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;807:3-11.
23. Maeda N, Shiga T. Inhibition and acceleration of erythrocyte aggregation induced by small macromolecules. Biochim Biophys Acta. 1985;843:128-136.
24. Chien S. Biophysical behabior of red cells in suspensions. In: Surgenor D. editor. The red blood cell. 2nd ed. New York: Academic Press; 1975. p. 1031-1133.
25. Chien S, Jan KM. Red cell aggregation by macromolecules: roles of surface adsorption and electrostatic repulsion. J Supramol Struct. 1973;1:385-409.
26. Baumler H, Neu B, Donath E, Kiesewetter H. Basic phenomena of red blood cell rouleaux formation. Biorheology. 1999;36:439-442.
27. Katchalsky A, Danon D, Nevo A. Interactions of basic polyelectrolytes with the red blood cell. II. Agglutination of red blood cells by polymeric bases. Biochim Biophys Acta. 1959;33:120-138.
28. Li C. Poly(L-glutamic acid) - anticancer drug conjugates. Adv Drug Deliv Rev. 2002;54:695-713.
29. Iwasaki Y, Mikami A, Kurita K, Yui N, Ishihara K, Nakabayashi N. Reduction of surface-induced platelet activation on phospholipid polymer. J Biomed Mater Res. 1997;36:508-515.
30. Iwasaki Y, Ijuin M, Mikami A, Nakabayashi N, Ishihara K. Behavior of blood cells in contact with water-soluble phospholipid polymer. J Biomed Mater Res. 1999;46:360-367.
31. Ishihara K, Ueda T, Nakabayashi N. Preparation of phospholipid polymers and their propaties as polymer hydrogel membranes. Polymer Journal. 1990;22:355-360.
32. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62:489-496.
33. Fijnheer R, Pietersz RN, de Korte D, Gouwerok CW, Dekker WJ, Reesink HW, et al. Platelet activation during preparation of platelet concentrates: a comparison of the platelet-rich plasma and the buffy coat methods. Transfusion. 1990;30:634-638.
34. Ishihara K, Ziats NP, Tierney BP, Nakabayashi N, Anderson JM. Protein adsorption from human plasma is reduced on phospholipid polymers. J Biomed Mater Res. 1991;25:1397-1407.
35. Ishihara K, Oshida H, Endo Y, Ueda T, Watanabe A, Nakabayashi N. Hemocompatibility of human whole blood on polymers with a phospholipid polar group and its mechanism. J Biomed Mater Res. 1992;26:1543-1552.
36. Ishihara K, Nomura H, Mihara T, Kurita K, Iwasaki Y, Nakabayashi N. Why do phospholipid polymers reduce protein adsorption? J Biomed Mater Res. 1998;39:323-330.
37. Sawada S, Sakaki S, Iwasaki Y, Nakabayashi N, Ishihara K. Suppression of the inflammatory response from adherent cells on phospholipid polymers. J Biomed Mater Res A. 2003;64:411-416.
38. Iwasaki Y, Sawada S, Ishihara K, Khang G, Lee HB. Reduction of surface-induced inflammatory reaction on PLGA/MPC polymer blend. Biomaterials. 2002;23:3897-3903.